Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
29 July 2020 - 6:05AM
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it
will report second quarter financial results and provide a
corporate update on August 4, 2020. The company will also host a
conference call that day at 5:00 p.m. Eastern Time (2:00 p.m.
Pacific Time).
Conference Call InformationTo
participate, dial 1-800-353-6461 from the United States or
1-334-323-0501 internationally approximately ten minutes before the
start of the call. The passcode will be 6800706.
A replay will be available through August 18, 2020 at
1-888-203-1112 from the United States and 1-719-457-0820
internationally. The passcode will be 6800706.
About Corcept Therapeutics Incorporated
Corcept is a commercial-stage company engaged in
the discovery and development of drugs to treat severe metabolic,
oncologic and psychiatric disorders by modulating the effects of
the stress hormone cortisol. Korlym® was the first drug approved by
the U.S. Food and Drug Administration for patients with Cushing’s
syndrome. Corcept has discovered a large portfolio of proprietary
compounds, that selectively modulate the effects of cortisol. The
company owns extensive United States and foreign intellectual
property covering the composition of its selective cortisol
modulators and the use of cortisol modulators to treat a variety of
serious disorders.
CONTACT:Christopher S. James, MDDirector,
Investor RelationsCorcept
Therapeutics650-684-8725cjames@corcept.comwww.corcept.com
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Apr 2024 to May 2024
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From May 2023 to May 2024